Citigroup began coverage on shares of Danaher (NYSE:DHR – Get Free Report) in a research report issued on Tuesday. The brokerage set a “buy” rating and a $230.00 price target on the conglomerate’s stock. Citigroup’s price target indicates a potential upside of 33.02% from the company’s current price.
A number of other research analysts have also issued reports on DHR. Wall Street Zen cut shares of Danaher from a “buy” rating to a “hold” rating in a report on Saturday, April 25th. Jefferies Financial Group restated a “buy” rating and issued a $245.00 price objective on shares of Danaher in a report on Tuesday, April 21st. The Goldman Sachs Group decreased their price objective on shares of Danaher from $265.00 to $230.00 and set a “buy” rating for the company in a research report on Monday, April 13th. Rothschild & Co Redburn set a $205.00 target price on Danaher in a report on Friday, April 17th. Finally, Royal Bank Of Canada initiated coverage on Danaher in a research note on Thursday, May 14th. They set an “outperform” rating and a $200.00 target price for the company. Twenty equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, Danaher has a consensus rating of “Moderate Buy” and an average target price of $238.24.
View Our Latest Report on Danaher
Danaher Trading Up 0.5%
Danaher (NYSE:DHR – Get Free Report) last posted its earnings results on Monday, April 20th. The conglomerate reported $2.06 earnings per share for the quarter, beating the consensus estimate of $1.94 by $0.12. Danaher had a net margin of 14.89% and a return on equity of 10.91%. The firm had revenue of $5.95 billion during the quarter, compared to the consensus estimate of $6 billion. During the same quarter last year, the firm earned $1.88 EPS. The firm’s revenue for the quarter was up 3.7% on a year-over-year basis. Sell-side analysts predict that Danaher will post 8.43 earnings per share for the current fiscal year.
Hedge Funds Weigh In On Danaher
Institutional investors have recently bought and sold shares of the company. Main Street Group LTD purchased a new position in Danaher in the first quarter worth $25,000. JPL Wealth Management LLC purchased a new position in shares of Danaher in the 3rd quarter valued at about $25,000. Elevated Capital Advisors LLC purchased a new position in shares of Danaher in the 4th quarter valued at about $26,000. WFA of San Diego LLC acquired a new stake in shares of Danaher in the second quarter valued at about $26,000. Finally, ANTIPODES PARTNERS Ltd acquired a new position in Danaher during the third quarter worth about $27,000. 79.05% of the stock is owned by institutional investors and hedge funds.
About Danaher
Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
Recommended Stories
- Five stocks we like better than Danaher
- AutoZone’s Pullback Sets Up a Long-Term Buying Opportunity
- AST SpaceMobile’s June Launch Plan Puts Its 2026 Satellite Goal Back in Focus
- 3 Defense Giants Boosting Dividends as Shares Take a Ride
- Powerhouse Williams-Sonoma Heading to Fresh Highs in 2026
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
